Clinical Scientist/Sr. Clinical Scientist (Early Oncology Development) - Scorpion Therapeutics
San Francisco, CA
About the Job
Scorpion is a pioneering clinical-stage oncology company redefining the frontier of precision medicine to deliver optimized and transformational therapies for larger populations of patients with cancer. Scorpion has built a proprietary and fully integrated platform of the most advanced technologies across cancer biology, medicinal chemistry, and data sciences, with the goal of consistently and rapidly creating exquisitely selective small molecule compounds against an unprecedented spectrum of targets. Scorpion aims to leverage its platform to advance a broad pipeline of wholly owned, optimized compounds across three target categories: best-in-class molecules targeting validated oncogene targets; first-in-class molecules for previously undruggable targets; and first-in-class molecules for novel cancer targets.
Title: Clinical Scientist/Sr. Clinical Scientist (Early Oncology Development)
Location: San Francisco/Boston/Remote
Job Summary
Our Clinical Development team has an exciting new opportunity for someone to join as a Contract Director/Senior Director, Clinical Science (Early Development). This person will provide scientific and clinical expertise to develop, design, conduct, analyze, and report global clinical trials in accordance with approved clinical development plans and Health Authority (e.g., FDA/EMA, etc.) regulatory requirements.
Key Responsibilities
- Contribute to oversight of trials in start-up, conduct, and close-out, for Phase I-III in close coordination with Clinical Operations
- Participate in critical site-facing activities (PSVs, SIVs, etc.); contribute to preparation of meeting materials in collaboration with the Clinical Trial Lead.
- Coordinate and conduct regular data/safety/efficacy reviews and identify trends across programs in collaboration with the Global Medical Monitor
- Contribute to the cross functional trial team as the clinical sciences lead.
- Participate with the study team to prepare for and execute regulatory milestones
- Contribute to the development of study documents for activities around study conduct (e.g., protocols, IBs, eCRFs, meeting abstracts, manuscripts, RECIST/IWG training materials), regulatory requirements (e.g., briefing documents), and IDMCs (e.g., charters)
- Work with statisticians/biometrics to develop the required tables/listings/figures and contribute to the interpretation of efficacy and safety data from clinical trials.
- Present safety findings and study status to internal stakeholders (e.g., safety working group/senior management meetings)
- Coordinate presentations at IDMC meetings, and other meetings, such as Investigator and Safety Review Meetings
- Participate in various initiatives and duties as required by the clinical development program.
Professional Experience/Qualifications
- Advanced degree (PharmD, MD, DO, PA, NP, PhD, etc.) in science is required, and 1+ years of experience in clinical research and/or drug development within the pharmaceutical industry.
- Prior drug development experience in oncology is preferred
- Experience using Medidata EDC and data visualization programs (e.g., R-Shiny, SAS, SpotFire, Tableu, Excel Pivot Tables, etc.) is preferred
- Experience in developing relationships with key investigators and KOLs
- Knowledge of GCP/ICH, study design, statistics, and basic clinical operations required
- Experience writing, editing, and reviewing protocols, informed consent templates, study manuals, conference presentations, and journal publications
- Team oriented, goal-driven, organized, and highly collaborative
- Excellent written and oral communication skills
- Ability to adapt in a fast-paced, agile team environment
Scorpion Therapeutics Inc. is an Equal Opportunity Employer who strives to create and maintain a diverse working environment. We do not discriminate for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Beginning October 13, 2021, Scorpion Therapeutics requires all new hires to be fully vaccinated against COVID-19. If you are unable to receive the vaccine due to a disability or serious medical condition, or because of your sincerely held religious beliefs, you will have an opportunity to request a reasonable accommodation.